Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: Seeing Machines CFO makes share purchase

(Sharecast News) - Seeing Machines revealed on Wednesday that chief financial officer Martin Ive had acquired 900,000 ordinary shares in the AIM-listed technology group. Ive, who was named as CFO in November, purchased the shares on Tuesday at an average price of 6.40p each, for a total value of £57,600.

Back in December, Seeing Machines told investors that it had been appointed by an existing tier-one customer to deliver its FOVIO driver and occupant monitoring system - a programme that carries an initial lifetime value of $32.0m.

As of 1620 GMT, Seeing Machines shares were up 1.88% at 6.52p.

Reporting by Iain Gilbert at Sharecast.com

Top Director Buys

Berkeley Group Holdings (the) (BKG) Director name: Adams ,Natasha Amount purchased: 1,947 @ 4,087.63p Value: £79,586.08

Seeing Machines Ltd. Npv (di) (SEE) Director name: Ive,Martin Amount purchased: 900,000 @ 6.40p Value: £57,600.00

Intercede Group (IGP) Director name: Hoggarth,Royston Amount purchased: 18,500 @ 55.77p Value: £10,317.45

Intercede Group (IGP) Director name: Hoggarth,Royston Amount purchased: 12,500 @ 55.25p Value: £6,906.25

Yourgene Health (YGEN) Director name: Chang,Bill Amount purchased: 2,000,000 @ 0.31p Value: £6,200.00

Team (TEAM) Director name: Clubb,Jonathan Mark Gordon Amount purchased: 10,000 @ 56.94p Value: £5,694.00

Odyssean Investment Trust (OIT) Director name: Cecil ,Arabella Amount purchased: 2,803 @ 181.00p Value: £5,073.43

Yourgene Health (YGEN) Director name: Chang,Bill Amount purchased: 1,000,000 @ 0.32p Value: £3,200.00

Yourgene Health (YGEN) Director name: Chang,Bill Amount purchased: 1,000,000 @ 0.31p Value: £3,100.00

Triple Point Social Housing Reit (SOHO) Director name: Coward,Peter Amount purchased: 813 @ 60.24p Value: £489.78

Croda International (CRDA) Director name: Foots,Steve Amount purchased: 3 @ 6,740.00p Value: £202.20

Prudential (PRU) Director name: FitzPatrick,Mark Amount purchased: 15 @ 1,242.75p Value: £186.41

Centrica (CNA) Director name: Ringrose ,Kate Amount purchased: 165 @ 91.23p Value: £150.53

Xp Factory (XPF) Director name: Bird,Graham Amount purchased: 1,029 @ 14.58p Value: £149.98

Xp Factory (XPF) Director name: Harpham,Richard Amount purchased: 1,029 @ 14.58p Value: £149.98

Centrica (CNA) Director name: OÂ'Shea,Chris Amount purchased: 164 @ 91.23p Value: £149.62

Mondi (MNDI) Director name: King,Andrew Amount purchased: 10 @ 1,492.41p Value: £149.24

Mondi (MNDI) Director name: Powell,Mike Amount purchased: 10 @ 1,492.41p Value: £149.24

Oxford Instruments (OXIG) Director name: Barkshire,Ian Amount purchased: 7 @ 2,122.00p Value: £148.54

Oxford Instruments (OXIG) Director name: Hill,Gavin Amount purchased: 7 @ 2,122.00p Value: £148.54

Imi (IMI) Director name: Twite,Roy Amount purchased: 10 @ 1,420.00p Value: £142.00

Croda International (CRDA) Director name: Maiden,Jez K Amount purchased: 2 @ 6,740.00p Value: £134.80

Imi (IMI) Director name: Shook ,Daniel Amount purchased: 9 @ 1,420.00p Value: £127.80

Top Director Sells

Share this article

Related Sharecast Articles

Director dealings: Blue Coast raises stake in Everyman Media
(Sharecast News) - Everyman Media revealed on Thursday that Blue Coast had acquired 50,000 ordinary shares in the AIM-listed cinema group.
Director dealings: Angus Energy CEO ups stake
(Sharecast News) - Angus Energy revealed on Wednesday that chief executive Richard Herbert had acquired 5.0m ordinary shares in the AIM-listed onshore oil and gas development firm.
Director dealings: Abrdn CEO makes share sale
(Sharecast News) - Abrdn revealed on Monday that chief executive Stephen Bird had disposed of 29,942 ordinary shares in the FTSE 250-listed global investment company.
Director dealings: Redx Pharma CEO ups stake
(Sharecast News) - Redx Pharma revealed on Friday that chief executive Lisa Anson had acquired 399,000 ordinary shares in the AIM-listed clinical-stage biopharmaceutical firm.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.